Oppenheimer Holdings, Inc. initiated coverage on shares of Mesoblast Limited (NASDAQ:MESO) in a report issued on Thursday. The firm issued an outperform rating and a $16.00 price objective on the stock.

Several other equities analysts have also recently commented on MESO. Zacks Investment Research cut shares of Mesoblast Limited from a buy rating to a sell rating in a research note on Wednesday, May 17th. Cantor Fitzgerald initiated coverage on shares of Mesoblast Limited in a research report on Wednesday, June 7th. They set a buy rating and a $20.00 target price for the company. Credit Suisse Group set a $11.00 price objective on shares of Mesoblast Limited and gave the stock a hold rating in a report on Tuesday, July 18th. Maxim Group set a $14.00 price objective on shares of Mesoblast Limited and gave the stock a buy rating in a report on Thursday, May 25th. Finally, BidaskClub lowered shares of Mesoblast Limited from a sell rating to a strong sell rating in a report on Friday, July 28th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the stock. The company has a consensus rating of Hold and an average target price of $13.64.

Mesoblast Limited (NASDAQ MESO) traded up 3.21% during mid-day trading on Thursday, reaching $6.10. 83,348 shares of the company’s stock were exchanged. Mesoblast Limited has a 52-week low of $4.01 and a 52-week high of $12.50. The stock’s market cap is $517.79 million. The company has a 50-day moving average of $7.03 and a 200-day moving average of $8.25.

TRADEMARK VIOLATION NOTICE: This piece of content was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece of content on another site, it was stolen and republished in violation of U.S. and international copyright legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/01/mesoblast-limited-meso-coverage-initiated-by-analysts-at-oppenheimer-holdings-inc.html.

A hedge fund recently raised its stake in Mesoblast Limited stock. Princeton Capital Management Inc. increased its position in shares of Mesoblast Limited (NASDAQ:MESO) by 15.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 155,700 shares of the company’s stock after buying an additional 20,945 shares during the period. Princeton Capital Management Inc. owned 0.20% of Mesoblast Limited worth $1,398,000 as of its most recent filing with the SEC. 2.95% of the stock is currently owned by institutional investors and hedge funds.

About Mesoblast Limited

Analyst Recommendations for Mesoblast Limited (NASDAQ:MESO)

Receive News & Stock Ratings for Mesoblast Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mesoblast Limited and related stocks with our FREE daily email newsletter.